AIDS Weekly articles from May 1994

AIDS Weekly archives from May 1994

FDA advisers recommend go-ahead for new AIDS drug. (Food and Drug Administration, stavudine, Zerit)
May 30, 1994... A panel of scientists recommended the government approve a new drug to battle HIV - but with strong warnings that doctors still don't know enough about the medicine to say who should take it. An advisory committee to the U.S. Food and...

Two new cases of AIDS transmission in households reported.
May 30, 1994... Two newly reported cases of AIDS transmitted between family members underscore the growing need to educate those providing or receiving care at home, a federal researcher said. Because of the social, economic and medical benefits, the...

Interim results of Phase II clinical trial reported. (of recombinant platelet factor-4)
May 30, 1994... Repligen Corporation and the Graduate Hospital of Philadelphia report interim results of a Phase II clinical trial with recombinant platelet factor-4 (rPF4) in Kaposi's sarcoma patients that demonstrate an antitumor response and help...

Phase I/II trials data. (of ImmunoGen's Oncolysin B)
May 30, 1994... Responses were seen in one-third of patients in Phase I/II clinical trials of ImmunoGen's Oncolysin B in AIDS patients with relapsed lymphoma. Data from that trial are being presented by Anil Tulpule, M.D., of the University of Southern...

Company awarded grant to develop anti-HIV agent. (Triplex Pharmaceutical Corp., nucleic acids)
May 30, 1994... Triplex Pharmaceutical Corporation, Woodlands, Texas, announced that it has been awarded a Phase I Small Business Innovation Research (SBIR) grant from the U.S. National Institutes of Health (NIH) to determine the feasibility of using...

Company chairman presents vision for growth. (Upjohn Chairman and CEO John L. Zabriskie)
May 30, 1994... Upjohn Chairman and CEO John L. Zabriskie outlined strategic priorities to achieve the company's new vision for growth. Zabriskie highlighted the potential of several promising compounds in the product pipeline. CPT-11, a recently...

Twice daily zidovudine delays onset of AIDS.
May 30, 1994... Zidovudine given twice daily significantly delayed the progression to symptomatic HIV disease among high -risk, asymptomatic HIV-infected patients, report members of the European-Australian Collaborative Group ("Zidovudine Twice Daily in...

Effect of ozone therapy on AIDS/hepatitis B patients.
May 30, 1994... Medizone International Inc., New York, New York, announced it began clinical trials with its Italian collaborators at the University of Naples to study the effects of Medizone (ozone/oxygen) therapy on patients suffering from AIDS and...

AIDS patient with MDR-TB no longer under quarantine. (multidrug-resistant tuberculosis)
May 30, 1994... A quarantine imposed on an AIDS patient with multidrug-resistant tuberculosis (MDR-TB) has been lifted by authorities of DeKalb County, Georgia, after a third sputum culture failed to produce Mycobacterium tuberculosis. "We believe...

Canadian patent issued for RBC-CD4 technology. (red blood cells for treatment of HIV infection and AIDS)
May 30, 1994... Sheffield Medical Technologies Inc., Houston, Texas, announced that a Canadian patent has been issued covering the red blood cell ("RBC")-CD4 and Liposome-CD4 technologies exclusively licensed by the company for the treatment of...

Researchers say window period averages 45 days. (time between HIV-1 infectivity to development of HIV-1 antibody)
May 30, 1994... The average time from the onset of HIV-1 infectivity to development of detectable HIV-1 antibody (window period) is 45 days, reported researchers from the U.S. Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, and the...

Swiss Red Cross hit by scandal. (using blood supplies contaminated with HIV)
May 30, 1994... The Swiss Red Cross, one of the country's most revered institutions, is embroiled in a scandal over its use of blood supplies contaminated with HIV. Earlier in May 1994, a Geneva prosecutor filed grievous bodily harm charges against...

88.2 million cases of TB to be seen in 1990s. (tuberculosis) (American Lung Association/American Thoracic Society)
May 30, 1994... The World Health Organization (WHO) reports that the already staggering global burden of tuberculosis (TB) will continue to worsen during the rest of the decade. During the 1990s WHO estimates that 88.2 million new cases of TB will...

HIV important risk factor for drug resistance. (American Lung Association/American Thoracic Society)
May 30, 1994... Among patients born in the United States, HIV is an important risk factor for tuberculosis (TB) drug resistance, even in areas where resistance is uncommon, according to a presentation to the 1994 American Lung Association/American Thoracic...

Chamber may ease AIDS fatigue. (hyperbaric pressure treatment)
May 30, 1994... Waiting to climb into a 15-foot tank that resembles a small submarine, a man describes how a treatment traditionally used to help divers suffering from the bends has helped him deal with AIDS. "I feel great, I almost feel guilty about...

Top killer of San Francisco men. (AIDS)
May 30, 1994... Health officials released statistics showing that for the year 1992 AIDS replaced heart disease and stroke as the leading killer of men in San Francisco, California. Dr. Sandra Hernandez, the city's public health director, called the...

Study: prognosis poor for longer term AIDS survival. (Europe)
May 30, 1994... A report from the AIDS in Europe Study Group finds the three-year survival rate among AIDS patients to be under 20 percent ("Survival Differences in European Patients with AIDS, 1979-1989," British Medical Journal, April 23,...

HIV-positive IDUS overdose at higher rate. (injecting drug users) (AIDS-Related Mortality)
May 30, 1994... HIV-positive injecting drug users (IDU) suffer a higher mortality due to drug overdose than is experienced by their HIV-negative counterparts, Italian researchers report ("Impact of HIV Infection on Non-AIDS Mortality among Italian...

IDUS more likely to use condom with non-IDU sex partners. (injecting drug users)
May 30, 1994... Injecting drug users (IDUs) use condoms more consistently with sex partners who are not themselves IDUs than with using partners, according to a recent report ("Consistent Condom Use in Relationships Between Seropositive Injecting Drug...

Scientists developing vaginal gel to protect against AIDS.
May 30, 1994... A seaweed extract commonly used in ice cream and candy is to be tested as a vaginal gel that could block HIV and allow women to protect themselves from infected sexual partners. Dr. Christopher J. Elias of the Population Council said...

Parasite in water keeps AIDS patients, others on edge. (cryptosporidium)
May 30, 1994... For hundreds of thousands, Milwaukee, Wisconsin's 1993 outbreak of a waterborne parasite caused a week or so of misery. For people with AIDS, HIV infection or advanced cancer, cryptosporidium is an ongoing nightmare of wondering...

First non-prescription drug for sexual disease considered. (genital herpes)
May 30, 1994... A drug company asked federal regulators to approve the first non-prescription drug for a sexually transmitted disease - medicine that could help 55 million Americans fight genital herpes. But the U.S. Centers for Disease Control and...

India tests herbal drugs for AIDS treatment.
May 30, 1994... India's top medical body announced it will begin AIDS-related clinical trials involving ancient Indian anti-degenerative herbal drugs claimed to arrest the spread of HIV. The government-funded Indian Council of Medical Research said a...

Needle exchange adopted. (Rhode Island)
May 30, 1994... Rhode Island joined the growing list of cities and states adopting needle exchange programs to help slow the spread of AIDS. A bill, signed by Governor Bruce Sundlun, allows state health officials to set up a pilot program to hand out...

Britain promises AIDS help to Zimbabwe.
May 30, 1994... Visiting Zimbabwe President Robert Mugabe emerged from talks with Prime Minister John Major with pledges of British help in battling AIDS. The United Kingdom will provide nine million pounds over the next five years for AIDS...

Control program not working on Indian subcontinent. (AIDS in the Developing World)
May 30, 1994... The number of Indians positive for HIV infection has increased by 25 percent in the past year, and the number with AIDS has doubled. Official estimates are that 15,000 are positive for the virus and that 559 people have AIDS....

Branch of association calls for HIV testing of surgical patients. (Australian Medical Association)
May 30, 1994... The New South Wales branch of the Australian Medical Association has called for the compulsory testing of all surgical patients for HIV, after a study revealed a high incidence of needlestick injuries in healthcare professionals. The...

Japanese teachers educated on AIDS education for children.
May 30, 1994... The University of California, San Francisco, AIDS Health Project's (AHP) commitment to stop the spread of HIV through education was shared internationally with a contingent of Japanese elementary school teachers. The AHP staff and local...

Institute launches hotline for cancer and AIDS pain. (Roxane Pain Institute)
May 30, 1994... Healthcare professionals and patients now have access to important information on cancer and AIDS pain management by calling the Roxane Pain Institute at (800) 335-9100. The toll-free number, established to provide callers with medical...

Dana-Farber grant for AIDS research renewed. (Dana-Farber Cancer Institute)
May 30, 1994... Dana-Farber Cancer Institute's grant for its work as a Center for AIDS Research (CFAR) has been renewed by the U.S. National Institute of Allergy and Infectious Diseases (NIAID). The grant was accorded NIAID's highest distinction and...

Free Radical Sciences Inc. completes $6.5 million financing.
May 30, 1994... Free Radical Sciences Inc., Cambridge, Massachusetts, a developer of pharmaceutical products for free radical -mediated diseases, announced that it has completed a $6.5 million private placement. New investors participating in the...

Study finds risk of mood disorder higher among homosexuals. (depressive mood disorder)
May 30, 1994... A North Carolina study found that the extent of depressive mood disorder among HIV-positive and HIV -negative homosexuals was comparable to that of the same population dwelling in epicenters of the epidemic ("Mood Disorders in HIV...

Evaluation of the Murex SUDS HIV-1 antibody test in a mixed population. (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "Serum specimens from 304 patients and 116 blood donors were tested for HIV-1...

A similar microbiologic profile in HIV-seropositive (HIV+) and seronegative (HIV-) women with pelvic inflammatory disease (PID). (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "To compare the microbiologic findings in HIV(+) women with PID who may be...

Immunomagnetic capture of CD4+ cells from whole blood for HIV detection by PCR. (polymerase chain reaction) (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "Rapid diagnosis of HIV infection may be greatly facilitated by direct...

VIDAS vs ELISA in the serodiagnosis of HIV-1 + 2, rubella and toxoplasma. (Vitek Immuno Diagnostic Assay Systems) (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "Rapid, automated and self-contained instruments that minimize exposure to...

Evaluation of a direct ELISA HIV-1/HIV-2 EIA using synthetic peptides; DETECT-HIVTM (version 2). (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "A direct ELISA version of BioChem ImmunoSystems' synthetic peptide EIA was...

Antibody profile and isotopic patterns on HIV-infected patients under drug treatment. (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "In this study we correlated the isotype and specificity of the IgG antibody...

Screening a low prevalence population for HIV-2 using a combination HIV-1/HIV-2 enzyme immunoassay and an immunofluorescence assay. (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "The Montana Public Health Laboratory has conducted screening for HIV-1 since 1985...

Cellular mechanisms account for decreased anti-HIV-1 activity of nucleoside analogs. (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "We tested whether cellular mechanisms (cell resistance) may account for decreased...

The upregulation of the promoter gene encoding the p105/p50 subunit of NF-kappa-B by HIV is dependent upon one specific kappa-B motif. (Research Report)
May 30, 1994... According to an abstract submitted by the authors to the 94th Meeting of the American Society for Microbiology, held May 23-27, 1994, in Las Vegas, Nevada, "Our previous cloning and sequencing of the promoter of the gene encoding the p50...

CD4+ blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection. (interferon-alpha) (Periodical Report) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in the Journal of Immunology, "We determined the relative abilities of cell subpopulations from all major PBMC lineages of normal donors to produce IFN-alpha in response to in vitro...

Functional and phenotypic change of T cells in murine acquired immune deficiency. (Periodical Report) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in the Journal of Immunology, "Infection of susceptible C57BL/6 mice with defective LP-BM5 murine leukemia virus causes disease termed murine acquired immune deficiency syndrome...

HLA class II antigens and the HIV envelope glycoprotein gp 120 bind to the same face of CD4. (human lymphocyte antigens) (Periodical Report) (Abstract) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in the Journal of Immunology, "Although the HIV gp120 binding site of CD4 is well characterized, its interaction site with HLA class II molecules is still controversial....

In vivo induction of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes and delayed-type hypersensitivity by a 23-amino acid peptide from the highly conserved region in major core protein p24.
May 30, 1994... According to the authors' abstract of an article published in Vaccine, "Cell-mediated immune responses are a major immune defence mechanism against the spread of human immunodeficiency, virus type 1 (HIV-1) which may lead to acquired immune...

Direct comparison of the relationship between clinical outcome and change in CD4+ lymphocytes in human immunodeficiency virus-positive homosexual men and injecting drug users. (Periodical Report) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in Archives of Internal Medicine, "Background and Methods: To compare rates of decline of CD4(+) lymphocytes among human immunodeficiency virus-positive lymphocytes among human...

Maternal antibody response at delivery and perinatal transmission of human immunodeficiency virus type 1 in African women. (Periodical Report) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in the Lancet, "Prospective cohort studies indicate that 13-45% of human immunodeficiency virus type 1 (HIV-1)-infected pregnant women transmit the virus to their infants. Although...

Two-year HIV-1-associated mortality in a Ugandan rural population. (Periodical Report) (Abstract) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in the Lancet, "The mortality in 15 villages in South-West Uganda was studied in relation to HIV infection. After a population census, serum samples were tested for antibodies to...

High rate of HIV seroconversion among patients attending urban sexually transmitted disease clinics - short communication. (Periodical Report) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in AIDS, "Objective: To study rates of documented HIV seroconversion and syphilis as a cofactor for seroconversion in sexually transmitted disease (STD) clinics. In the main...

HIV-1 infection among lower class commercial sex workers in Chiang Mai, Thailand - short communication. (Periodical Report) (Abstract)
May 30, 1994... According to the authors' abstract of an article published in AIDS, "Objective: To determine risk factors for HIV-1 infection in female commercial sex workers (CSW) in northern Thailand. Methods: A cross-sectional survey of female CSW...

Controversy arises over what Red Cross knew about HIV risk in 1983. (transfusion-associated AIDS)
May 23, 1994... Transfusion-Associated AIDS Even though American Red Cross officials were aware of the risk of transfusion-associated AIDS in 1983 -before blood tests were available - they refused to screen blood for surrogate markers for HIV,...

Lower incidence of AIDS-related pneumonia found in blacks. (Pneumocystis carinii pneumonia)
May 23, 1994... Study The largest ongoing AIDS study of its kind has made an unexpected, startling finding: black persons with AIDS are much less likely than whites to contract Pneumocystis carinii pneumonia (PCP), a leading cause of illness and...

HIV vaccine conference calls for community support.
May 23, 1994... Vaccine It's not only laboratory scientists who have a tough job ahead of them to find a vaccine for HIV. The search for a preventive vaccine may not be successful unless a range of community members - from family practitioners to...

Oral vaccine against sexual transmission of HIV tested.
May 23, 1994... Vaccine Researchers at the Johns Hopkins Medical Institutions, Baltimore, Maryland, and the University of Rochester Medical Center, New York, are recruiting volunteers to test the first oral AIDS vaccine, developed specifically to...

Baxter receives FDA license to market drug. (Baxter Healthcare Corp., Food and Drug Administration)(Gammagard S/D, Immune Globulin Intravenous, Human)
May 23, 1994... Immunotherapy Baxter Healthcare Corporation, Hyland Division, announced that the U.S. Food and Drug Administration (FDA) has licensed Hyland to market solvent/detergent -treated Gammagard S/D, Immune Globulin Intravenous (Human) in the...

Genelabs reports development progress for AIDS. (Genelabs Technologies Inc.'s GLQ223 alpha-trichosanthin)
May 23, 1994... Update Genelabs Technologies Inc. announced at the annual shareholders' meeting that it has completed analysis of the data from a Phase II clinical trial of GLQ223 (alpha -trichosanthin) for treatment of patients with AIDS or AIDS...

Call for resignation of Gebbie as AIDS Policy Coordinator. (Kristine Gebbie)(National Association of People with AIDS)
May 23, 1994... AIDS Coordinator The following was released by William J. Freeman, executive director of the National Association of People with AIDS: The National Association of People with AIDS (NAPWA) calls for the resignation of Kristine...

Foscarnet therapy effective against CMV in the ganciclovir-resistant. (cytomegalovirus retinitis)
May 23, 1994... Therapies Salvage therapy with foscarnet in patients who had grown intolerant of ganciclovir proved to slow the progression of cytomegalovirus (CMV) retinitis, according to a recent report ("Phase II Dose-Ranging Trial of Foscarnet...

Companies sign research agreement. (Progenics Pharmaceuticals Inc., American Cyanamid Co.)
May 23, 1994... Joint Venture Progenics Pharmaceuticals Inc., Tarrytown, New York, announced the signing of a research agreement with American Cyanamid Company, Wayne, New Jersey, to develop a new class of therapeutic products for treating HIV...

AIDS activists protest MDR-TB patient's confinement. (multidrug-resistant tuberculosis) (Atlanta, Georgia)
May 23, 1994... Quarantine AIDS activists protesting the quarantine of an Atlanta, Georgia, man with multidrug-resistant tuberculosis (MDR-TB) stopped traffic in downtown Atlanta and experienced five arrests. The patient in question, who has...

More study of rise in TB rate among children with HIV. (tuberculosis)
May 23, 1994... HIV and TB The rate of tuberculosis (TB) in children exposed to HIV appears to be rising but additional research is needed, a Duke University Medical Center researcher reported. A retrospective survey conducted at 70 sites...

Center testing new drugs to prevent disease. (New Jersey Medical School's National Tuberculosis Center)
May 23, 1994... TB Drugs Health officials battling the worldwide epidemic of tuberculosis (TB), an infectious disease once believed nearly eliminated, are targeting the most vulnerable people: those also infected with HIV. Researchers said...

Study finds differences in AIDS-related TB. (tuberculosis)
May 23, 1994... Complications A New Jersey review found "vast" differences in the clinical, roentgenographic and drug susceptibility characteristics of patients with tuberculosis (TB) who did and did not have AIDS. In an effort to shed light on...

West African patients with TB at high risk for HBV. (tuberculosis, hepatitis B virus)
May 23, 1994... Disease Association A West African study suggests that patients with tuberculosis (TB) should be considered at high risk for hepatitis B as well as AIDS. A.O. Adebajo et al. studied the seroepidemiological associations of TB,...

Phagocytosis of M. tuberculosis may enhance HIV transcription. (Mycobacterium tuberculosis)
May 23, 1994... Virology Phagocytosis of M. tuberculosis may enhance human immunodeficiency virus (HIV) transcription in monocytic cells although it may reduce release of intact HIV, according to a report from Great Britain. HIV replication has...

Disseminated TB with septic shock seen in AIDS patient. (tuberculosis)
May 23, 1994... Atypical Disease M. tuberculosis should be considered a possible cause of septic shock in HIV-infected patients, and testing for HIV should be recommended in all patients with unusual manifestations of tuberculosis (TB), according to a...

WHO recommends strategies for HIV testing without WB. (World Health Organization; Western blot test)
May 23, 1994... World Health Organization Officials from the World Health Organization (WHO) have proposed strategies to use in settings where resources are limited that do not require the use of Western blot (WB) of sera in testing for the presence...

EPA: dioxin risk in food chain. (Environmental Protection Agency)
May 23, 1994... Drug Risk Exposure to even minute traces of dioxin, much of it through the food chain, poses wider health risks than had been suspected and may harm the human immune system and fetal development, according to preliminary results of a...

Zidovudine useful in forestalling AIDS in ARC patients. (AZT; AIDS-related complex)
May 23, 1994... AIDS Therapies Zidovudine may significantly delay the onset of AIDS in patients with AIDS-related complex (ARC), Australian researchers report ("Efficacy of Zidovudine Treatment in Homosexual Men with AIDS-Related Complex: Factors...

Incidence of Army HIV infection consistent with projections.
May 23, 1994... At Risk Populations The incidence of HIV infection in a population consisting of members of the U.S. Army Reserve Components (RC) is consistent with projections that AIDS incidence in the U.S. will plateau in the middle to late 1990s,...

Antifungals prove prophylactic for esophageal candidiasis relapse.
May 23, 1994... Opportunistic Infections Prophylactic administration of both ketoconazole and fluconazole proved effective against recurrences of esophageal candidiasis in a recent Italian study ("Prevention of Symptomatic Recurrences of Esophageal...

Stains assessed for detection of MAI infection. (Mycobacterium avium-intracellulare)
May 23, 1994... Opportunistic Infections Researchers from the University of Texas Southwestern Medical Center, Dallas, found anti-M. duvalii and anti -BCG to be more sensitive than acid-fast stains in the detection of Mycobacterium...

Mortality rate skyrockets among seropositive families. (Zaire)
May 23, 1994... Children of AIDS Researchers in Kinshasa, Zaire, report that maternal, paternal and early childhood mortality rates in families in which the mother is seropositive for HIV-1 range five-to tenfold greater than in families in which the...

Self-quiz helps women assess STD risk. (sexually transmitted diseases)
May 23, 1994... STD A new self-quiz that helps women assess their risk for sexually-transmitted disease (STD) and unplanned pregnancy was introduced to physicians for use in their offices at a national meeting of obstetricians and gynecologists. ...

Medical professionals caring for AIDS patients studied.
May 23, 1994... AIDS Study Hospice care of AIDS patients is both satisfying and stressful is the focus of a new report from the Center for Washington Area Studies at the George Washington (GW) University, Washington, D.C. "AIDS Care in Six...

An acutely lethal simian immunodeficiency virus acts as a superantigen. (Research Report)
May 23, 1994... AUTHORS: Z.W. Chen, Z.-C. Kou, D. Lee-Parritz, P.N. Fultz and N.L. Letvin. Harvard Medical School, New England Primate Research Center, Southboro, Massachusetts; and University of Alabama, Department of Microbiology, Birmingham, Alabama....

Treatment with zidovudine (AZT) is not associated with increased B-cell activation in HIV infection. (Research Report)
May 23, 1994... AUTHORS: D. Widney, M. Vander Meyden and O. Martinez -Maza. University of California, Schools of Medicine and Public Health, Los Angeles, California. According to an abstract submitted by the authors to the Eighty-Fifth Meeting of the...

Chemotherapy associated with zidovudine and GM-CSF in human immunodeficiency virus-related non-Hodgkin's lymphoma (HIV-NHL). (granulocyte-macrophage colony stimulating factor) (Research Report)
May 23, 1994... AUTHORS: J. Gabarre, E. Lepage, A. Thyss, Y. Bastion, C. Sebban, D. Schlaifer, V. Ribrag, M. Fereres, M. Raphael and C. Gisselbrecht. Saint-Louis Hospital, GELA Program, Paris, France. According to an abstract submitted by the authors...

Pediatric HIV-associated non-Hodgkin's lymphomas. (Research Report)
May 23, 1994... AUTHORS: A. Shad, K. Bhatia, N. Hamdy, B. Mueller, P. Pizzo, J. Whang Peng, E. Jaffe and I. Magrath. U.S. National Cancer Institute, Division of Cancer Therapy, Bethesda, Maryland. According to an abstract submitted by the authors to...

HIV lymphomas frequently carry mutations in the c-myc protein. (Research Report)
May 23, 1994... AUTHORS: G. Spangler, G. Gaidano, N. Hamdy, R. Dalla -Favera, I. Magrath and K. Bhatia. U.S. National Cancer Institute, Pediatric Branch, Bethesda, Maryland; and Columbia University, Department of Pathology, New York, New York. ...

HIV-crossreactive antigens in breast and gynecological cancer. (Research Report)
May 23, 1994... AUTHORS: E.M. Rakowicz Szulczynska, D.G. Mcintosh, J. Piao and M. Smith. University of Nebraska, Medical Center, Omaha, Nebraska. According to an abstract submitted by the authors to the Eighty-Fifth Meeting of the American...

Elevated serum levels of a 90 kDa tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV). (Research Report)
May 23, 1994... AUTHORS: C. Natoli, N. Tinari, M. D'Egidio, F. Ghinelli, O. Fusco, N. D'Ostilio, A. Grassadonia, L. Ortona, M. Piazza and S. Iacobelli. University 'G. D'Annunzio', Chieti, Italy; S. Anna Hospital, Ferrara, Italy; Catholic University,...

Cost utility of Gomori methenamine silver stains in bronchoalveolar lavage specimens. (Research Report)
May 23, 1994... AUTHORS: S.S. Raab, M.B. Cohen, J.C. Cheville and Kent Bottles. University of Iowa Hospitals and Clinics, Iowa City, Iowa. According to an abstract submitted by the authors to a joint meeting of the American Society of Clinical...

Differential survival of patients with AIDS according to the 1987 and 1993 CDC case definitions. (Centers for Disease Control and Prevention) (Periodical Report) (Abstract)
May 23, 1994... SOURCE: Journal of the American Medical Association, April 20, 1994;271(15):1197-1199. According to the authors' abstract of an article published in the Journal of the American Medical Association, "Objective: To evaluate the...